+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • February 2023
  • 127 Pages
  • Global
From
Huntington Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Huntington Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 158 Pages
  • Global
From
Painful Diabetic Neuropathy Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Painful Diabetic Neuropathy Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 32 Pages
  • Global
From
Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 1452 Pages
  • Global
From
Friedreich Ataxia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Friedreich Ataxia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 92 Pages
  • Global
From
Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • November 2022
  • 330 Pages
  • Global
From
Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • November 2022
  • 205 Pages
  • Global
From
Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Insomnia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Insomnia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • July 2022
  • 639 Pages
  • Global
From
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape - Product Thumbnail Image

Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape

  • Report
  • May 2022
  • 63 Pages
  • Global
From
Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 283 Pages
  • Global
From
Neuromyelitis Optica (Devic's Syndrome) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Neuromyelitis Optica (Devic's Syndrome) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 103 Pages
  • Global
From
Alzheimer's Disease: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Alzheimer's Disease: Global Drug Forecast and Market Analysis to 2028

  • Report
  • May 2020
  • 218 Pages
  • Global
From
Alzheimer's Disease: Epidemiology Forecast to 2028 - Product Thumbnail Image

Alzheimer's Disease: Epidemiology Forecast to 2028

  • Report
  • May 2020
  • 47 Pages
  • Global
From
Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028

  • Report
  • December 2019
  • 356 Pages
  • Global
From
Parkinson's Disease: Global Drug Forecast and Market Analysis to 2026 - Product Thumbnail Image

Parkinson's Disease: Global Drug Forecast and Market Analysis to 2026

  • Report
  • May 2018
  • 127 Pages
  • Global
From
Neurological Disease Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Neurological Disease Treatment Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 240 Pages
  • Global
From
Guillain-Barre Syndrome Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Guillain-Barre Syndrome Treatment Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 240 Pages
  • Global
From
Multiple Sclerosis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Multiple Sclerosis Treatment Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
Rett Syndrome Market Report and Forecast 2024-2032 - Product Thumbnail Image

Rett Syndrome Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more